AndersonW.1991. The New York needle trial: The politics of public health in the age of AIDS. American Journal of Public Health, 81:1506–1517.
2.
CohenCathy J.1999. The Boundaries of Blackness: AIDS and the breakdown of Black politics. Chicago: University of Chicago Press.
3.
DerenSherryFullerCrystalPougetEnrique R.BlaneyShannonTortuStephanieKangSung-YeonMcMahonJames M.AndiaJonny F.Des JarlaisD.C.JohnsonBruceRosenblumAndrewVlahovDavid. 2003. Impact of Expanding Syringe Access in New York on Sources of Syringes for IDUs in Harlem and the Bronx. International Journal of Drug Policy, 14:373–379.
4.
Des JarlaisD.C.PerlisT.ArastehK.HaganH.MillikenJ.M.BraineN.YancovitzS.MildvanD.PerlmanD.C.MaslowC.FriedmanS.R.2004. “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Sydrome;35:158–166.
5.
Des JarlaisDon CCourtneyMcKnightPatriciaFriedmann. Legal Syringe Purchases by Injection Drug Users in Brooklyn and Queens, New York City, 2000–2001. 2003. Journal of the American Pharmaceutical Association, 42 (suppl 2):S73–76.
6.
Des JarlaisDon C.2002. Trends in HIV among IDUs in New York City. Presented at the International AIDS Conference, Barcelona, Spain.
7.
Des JarlaisDon CMichaelMarmorFriedmannPatriciaTitusS.AvilesE.DerenS.2000. HIV incidence among injection drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health, 90:352–359.
8.
Des JarlaisD.C.PerlisT. E.FriedmanS. R.ChapmanT.KwokJ.RockwellR.PaoneD.MillikenJ.MonterrosoE.2000. Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990–1997. American Journal of Public Health;90 (7):1112–1116.
9.
Des JarlaisD.C.MarmorM.PaoneD.TitusS.ShiQ.PerlisT.E.JoseB.FriedmanS.R.1996. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348:987–991.
10.
Des JarlaisDon C.SamuelR. FriedmanAIDS prevention programs for injecting drug users. 1992. In: Wormser ed. AIDS and other manifestations of HIV infection. New York: Raven Press: 645–658.
11.
FinkelsteinRuthTigerRebeccaGreenwaldRMukherjeeR.2002. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). Journal of the American Pharmaceutical Association;42 (suppl 2):S83–87.
12.
FrankBlanche. An overview of heroin trends in New York City: Past, present and future. 2000. The Mount Sinai Journal of Medicine; 67 (5,6):340–346.
13.
GostinLawrence O.LazzariniZitaJonesStevenFlahertyKathleen. 1997. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles. Journal of the American Medical Association, 277 (1), 53–62.
14.
HolmbergScott D.1996. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health;86 (5):642–654.
15.
HutchinsonSharon J.TaylorAvrilGoldbergDavid J.GruerLawrence. 2000. Factors associated with injecting risk behavior among serial community-wide samples of injecting drug users in Glasgow 1990–1994: Implications for control and prevention of blood-borne viruses. Addiction;95 (6):931–940.
16.
KleinSusan JCandelasAlma RBirkheadGuthrie S. 2002. Mobilizing Public and Private Partners to Support New York's Expanded Syringe Access Demonstration Program. Journal of the American Pharmaceutical Association;42 (suppl 2):S28–29.
17.
LurieP.DruckerE.1997. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet; 349:604–608.
18.
National Institutes of Health US. 1997. Interventions to prevent HIV risk behaviors. In: NIH Consensus Statement. National Institutes of Health.
19.
New York City Department of Health Office of AIDS Surveillance. 1999. AIDS in boroughs and neighborhoods of New York City. Volume 3; New York: NYC DOH.
20.
New York City Department of Health and Mental Hygiene. 2004. Bureau of Vital Statistics. Summary of Vital Statistics. New York, N.Y.: New York City Department of Health and Mental Hygiene.
21.
NormandJacquesDavidVlahovMosesLE, eds. 1995. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press.
22.
PaoneDeniseClarkJ.ShiQ.PurchaseDavid. 1999. Syringe exchange in the United States, 1996: A national profile. American Journal of Public Health, 89, 43–46.
23.
RockwellRussellDes JarlaisDon C.SamuelR. FriedmanPerlisTheresa E.PaoneD.1999. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care; 11 (4):437–442.
24.
RussellRockwellSherryDerenGoldsteinMarjorie F.FriedmanSamuel R.Des JarlaisDon C.2002. Trends in the AIDS epidemic among injection drug users: Localized or city-wide?Journal of Urban Health;79 (1):136–146.
25.
RockwellRussellJosephHermanFriedmanSamuel R.2004. Syringe technology, markets, and responses of injection drug users to the New York City AIDS epidemic. Submitted.
26.
SchoenbaumE.E.HartelD.M.GourevitchM.N.1996. Needle exchange use among a cohort of injecting drug users. AIDS;10 (14): 1729–34.
27.
SingerM.StopkaT.SianoC.SpringerK.BartonG.KhoshnoodK.Gorry dePuga A.HeimerR.2000. The social geography of AIDS and hepatitis risk: Qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health;90 (7): 1049–1056.
28.
TempalskiBarbaraFriedmanS.R.Des JarlaisD.C.McKnightC.KeemMarieFriedmanR.2003. What predicts which metropolitan areas in the USA have syringe exchanges?The International Journal of Drug Policy;14:417–424.
29.
WallaceRobert G.2003. AIDS in the HAART era: New York's heterogeneous geography. Social Science & Medicine; 56:1155–1171.
30.
WallaceRWallaceD.1993. The coming crisis of public health in the suburbs. The Milbank Quarterly, 71:543–564.